G. D. BJARNADOTTIR ;
A. MAGNUSSON ;
B. O. RAFNAR ;
E. SIGURDSSON ;
S. STEINGRIMSSON ;
M. JOHANNSSON ;
H. BRAGADOTTIR ;
H. M. HARALDSSON
|
2016
Dans European Addiction Research (Vol.22, n°5, August 2016) Article : Périodique
Dans European Addiction Research (Vol.22, n°5, August 2016) Article : Périodique
BACKGROUND/AIMS: Methylphenidate (MPH) has been the most commonly used intravenous (i.v.) substance in Iceland in recent years. In Iceland, MPH is available in 3 forms: immediate-release (IR) tablets (MPH IR, short-acting), sustainable-release ([...]
Historique